نتائج البحث 251-260 من 13526 لعملية البحث عن waardenburg syndrome
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. PLS ...
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's ...
Jean C. Fox, M.D.. Internist; Gastroenterologist. Rochester, MN. مناطق التركيز: Fundoplication, Pelvic floor dysfunction, Irritable bowel syndrome, ...
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...
Mayo Clinic researchers are continually developing improved screening methods and treatments for hereditary polyp disorders, such as Peutz-Jeghers syndrome, and ...
Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...
Rochester, Minn., Jacksonville, Fla. Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB. A Study of Lutetium Lu 177 Dotatate ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.